Pamela Tenaerts

Pamela Tenaerts is the Chief Scientific Officer at Medable. Pamela has previously served as the Executive Director Clinical Trials Transformation Initiative at Duke University, the Director of the Clinical Research Center and Center for Advanced Surgery at Sarasota Memorial Hospital, and the GUSTO II North American coordinator at Duke University.

Pamela Tenaerts received their medical degree from K.U.Leuven in Belgium. Pamela then completed a fellowship in cardiology at Duke University Medical Center. After their fellowship, they worked as a Clinical Research Physician at Pfizer for a year before taking on the role of Director, European Operations at CoAxia. In 2007, they returned to Duke University as the Executive Director Clinical Trials Transformation Initiative.

Pamela Tenaerts is a respected leader in the field of clinical research. Pamela has played a pivotal role in developing new treatments and improving patient care. Her work has helped transform the clinical trials process and has improved outcomes for patients around the world.

Pamela Tenaerts is a medical doctor who has a faculty position at the KU Leuven in Belgium. Pamela also has an MBA from the University of South Florida.

Pamela Tenaerts reports to Michelle Longmire, Co-Founder & CEO. Pamela Tenaerts works with Maryanne Rizk - Chief Strategy Officer, Jawahar Malhotra - EVP, Technology, and Fer Waigandt - Co-Founder & Director of Mobile Development.